ISSN: 2161-1165

Epidemiology: Open Access
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • Epidemiology (Sunnyvale) 2018, Vol 8(4): 358
  • DOI: 10.4172/2161-1165.1000358

Canaglifozin in the Diabetic-Obese and Poorly Controlled

Pedro J Tárraga López1,2*, Fatima Madrona Marcos1, Loreto Tarraga Marcos3, Carmen Celada Roldan4, Juan Solera Albero1, Jose Luis Castro Navarro1, Raul Salmeron Rios1, Angel Celada1, Ibrahim Sadek1 and JJ Atienza1
1Integrated Management of Albacete, Health Service of Castilla-La Mancha, Spain
2Castilla La Mancha University, Spain
3Clinical Hospital of Zaragoza, Spain
4Management of Cartagena, Murcian Health Service, Spain
*Corresponding Author : Pedro J Tárraga López, Health Service of Castilla-La Mancha, Albacete, Spain, Tel: +34609080627, Email: pjtarraga@sescam.jccm.es

Received Date: Oct 20, 2018 / Accepted Date: Nov 02, 2018 / Published Date: Nov 05, 2018

Abstract

Objective: To analyze the metabolic evolution in patients with previous poor control after starting treatment with canagliflozin.
Methodology: A retrospective observational study in patients with poor glycemic control assigned to several health centers of Albacete and Cuenca provinces in which treatment with canagliflozin has been started after 6 months. Variables are analyzed: age, sex, weight, height, BMI. Analytical variables: glycemia, glycated hemoglobin, total cholesterol, HDL, LDL, triglycerides, uric acid, C-reactive protein, urea, creatinine proteinuria
Results: 107 diabetic patients participated, 45.5% men, Average age 61, 16-23 years. Basal variable 6 months level signify Glucemia fasting 157.41-126.89, p>0.002 Hemoglobin glycated 8.55-6.91, p>0.003, Weight 84.31-80.21, p>0.002, BMI 31.66-30.04, p>0.04, Cholesterol T 199.05-188.61, p>0.03, LDL 113.36-97.102, p>0.05, TG 195.18-176.80, p>0.05.
Conclusion: The treatment with Canaglifozin 100 has been effective for the metabolic control of patients previously poorly controlled.

 

Keywords: Diabetes; Obesity; Bad control canaglifozina

Citation: Lopez PJT, Marcos FM, Marcos LT, Roldan CC, Albero JS, et al. (2018) Canaglifozin in the Diabetic-Obese and Poorly Controlled. Epidemiology (Sunnyvale) 8: 358. Doi: 10.4172/2161-1165.1000358

Copyright: © 2018 Lopez PJT, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top